{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fcannacast-il.simplecast.com%2Fepisodes%2Fmedicalizing-vaporization-Fm1_u8dS","width":444,"version":"1.0","type":"rich","title":"“Medicalizing Vaporization”","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/87cff0ab-cad9-4e7b-9e34-7615b173b9f8/113e9576-0e1c-4cb6-8b2c-feb664054838/cncst_1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/dc6fca42-8160-4a89-9c38-5871955aaa39\" height=\"200\" width=\"100%\" title=\"“Medicalizing Vaporization”\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In today’s podcast, we interview Avihu Tamir, Founder, and CEO of Kanabo Research. Kanabo has developed an innovative medical-grade vaporization device that provides metered doses at a standard of safety and quality that physicians can trust. \nThe vaporization device uses only 100% pure extracted pharmaceutical-grade cannabis with no added carriers or additives, with formulations targeted at specific medical indications. \nPotential distributors, as well as research partners looking to perform clinical trials using Kanabo’s platform, are invited to reach out at avihu@kanaboresearch.com   Kanabo website: https://www.kanabogroup.com/\n\n"}